Lipofibromatosis: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Lipofibromatosis | |||
| synonyms = | |||
| pronunciation = | |||
| image = | |||
| caption = | |||
| specialty = [[Pediatric oncology]], [[Dermatology]] | |||
| symptoms = [[Painless]] [[soft tissue mass]] | |||
| onset = [[Infancy]] or [[early childhood]] | |||
| duration = [[Chronic]] | |||
| types = | |||
| causes = [[Genetic mutations]] | |||
| risks = | |||
| diagnosis = [[Histopathology]], [[Imaging studies]] | |||
| differential = [[Fibrous hamartoma of infancy]], [[Infantile fibrosarcoma]], [[Myofibromatosis]] | |||
| prevention = | |||
| treatment = [[Surgical excision]] | |||
| medication = | |||
| prognosis = Generally [[benign]], but may [[recur]] | |||
| frequency = Rare | |||
| deaths = | |||
}} | |||
'''Lipofibromatosis''' is a rare, benign [[tumor]] that primarily affects children and young adults. It is characterized by the proliferation of mature adipose and fibrous tissue. | '''Lipofibromatosis''' is a rare, benign [[tumor]] that primarily affects children and young adults. It is characterized by the proliferation of mature adipose and fibrous tissue. | ||
==Epidemiology== | ==Epidemiology== | ||
Lipofibromatosis is a rare condition, with fewer than 50 cases reported in the medical literature. It affects both males and females equally and can occur at any age, but it is most commonly diagnosed in children and young adults. | Lipofibromatosis is a rare condition, with fewer than 50 cases reported in the medical literature. It affects both males and females equally and can occur at any age, but it is most commonly diagnosed in children and young adults. | ||
==Pathology== | ==Pathology== | ||
Lipofibromatosis is characterized by the proliferation of mature adipose and fibrous tissue. The tumor is typically well-circumscribed and can vary in size. Histologically, it is composed of mature adipocytes and fibroblasts, with a variable amount of collagen. The tumor cells do not show significant atypia or mitotic activity, which helps distinguish lipofibromatosis from malignant [[liposarcoma]]. | Lipofibromatosis is characterized by the proliferation of mature adipose and fibrous tissue. The tumor is typically well-circumscribed and can vary in size. Histologically, it is composed of mature adipocytes and fibroblasts, with a variable amount of collagen. The tumor cells do not show significant atypia or mitotic activity, which helps distinguish lipofibromatosis from malignant [[liposarcoma]]. | ||
==Clinical Presentation== | ==Clinical Presentation== | ||
Patients with lipofibromatosis typically present with a painless, slow-growing mass. The tumor can occur anywhere in the body, but it is most commonly found in the extremities, particularly the hands and feet. Other less common sites include the trunk, head and neck, and internal organs. | Patients with lipofibromatosis typically present with a painless, slow-growing mass. The tumor can occur anywhere in the body, but it is most commonly found in the extremities, particularly the hands and feet. Other less common sites include the trunk, head and neck, and internal organs. | ||
==Diagnosis== | ==Diagnosis== | ||
The diagnosis of lipofibromatosis is typically made based on the clinical presentation and histological findings. Imaging studies, such as [[magnetic resonance imaging]] (MRI), can be helpful in determining the extent of the tumor and planning for surgical resection. A biopsy of the tumor is usually performed to confirm the diagnosis. | The diagnosis of lipofibromatosis is typically made based on the clinical presentation and histological findings. Imaging studies, such as [[magnetic resonance imaging]] (MRI), can be helpful in determining the extent of the tumor and planning for surgical resection. A biopsy of the tumor is usually performed to confirm the diagnosis. | ||
==Treatment== | ==Treatment== | ||
The primary treatment for lipofibromatosis is surgical resection of the tumor. Complete resection is often curative, but the tumor can recur if not completely removed. In cases where complete resection is not possible, close follow-up is recommended to monitor for tumor growth. | The primary treatment for lipofibromatosis is surgical resection of the tumor. Complete resection is often curative, but the tumor can recur if not completely removed. In cases where complete resection is not possible, close follow-up is recommended to monitor for tumor growth. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for patients with lipofibromatosis is generally good, as the tumor is benign and does not metastasize. However, the tumor can cause significant morbidity if it involves critical structures or if it recurs after incomplete resection. | The prognosis for patients with lipofibromatosis is generally good, as the tumor is benign and does not metastasize. However, the tumor can cause significant morbidity if it involves critical structures or if it recurs after incomplete resection. | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Benign tumors]] | [[Category:Benign tumors]] | ||
[[Category:Pediatric diseases]] | [[Category:Pediatric diseases]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 23:02, 3 April 2025
| Lipofibromatosis | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Pediatric oncology, Dermatology |
| Symptoms | Painless soft tissue mass |
| Complications | N/A |
| Onset | Infancy or early childhood |
| Duration | Chronic |
| Types | |
| Causes | Genetic mutations |
| Risks | |
| Diagnosis | Histopathology, Imaging studies |
| Differential diagnosis | Fibrous hamartoma of infancy, Infantile fibrosarcoma, Myofibromatosis |
| Prevention | |
| Treatment | Surgical excision |
| Medication | |
| Prognosis | Generally benign, but may recur |
| Frequency | Rare |
| Deaths | |
Lipofibromatosis is a rare, benign tumor that primarily affects children and young adults. It is characterized by the proliferation of mature adipose and fibrous tissue.
Epidemiology[edit]
Lipofibromatosis is a rare condition, with fewer than 50 cases reported in the medical literature. It affects both males and females equally and can occur at any age, but it is most commonly diagnosed in children and young adults.
Pathology[edit]
Lipofibromatosis is characterized by the proliferation of mature adipose and fibrous tissue. The tumor is typically well-circumscribed and can vary in size. Histologically, it is composed of mature adipocytes and fibroblasts, with a variable amount of collagen. The tumor cells do not show significant atypia or mitotic activity, which helps distinguish lipofibromatosis from malignant liposarcoma.
Clinical Presentation[edit]
Patients with lipofibromatosis typically present with a painless, slow-growing mass. The tumor can occur anywhere in the body, but it is most commonly found in the extremities, particularly the hands and feet. Other less common sites include the trunk, head and neck, and internal organs.
Diagnosis[edit]
The diagnosis of lipofibromatosis is typically made based on the clinical presentation and histological findings. Imaging studies, such as magnetic resonance imaging (MRI), can be helpful in determining the extent of the tumor and planning for surgical resection. A biopsy of the tumor is usually performed to confirm the diagnosis.
Treatment[edit]
The primary treatment for lipofibromatosis is surgical resection of the tumor. Complete resection is often curative, but the tumor can recur if not completely removed. In cases where complete resection is not possible, close follow-up is recommended to monitor for tumor growth.
Prognosis[edit]
The prognosis for patients with lipofibromatosis is generally good, as the tumor is benign and does not metastasize. However, the tumor can cause significant morbidity if it involves critical structures or if it recurs after incomplete resection.
